Antibody
01
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Abelacimab is under investigation in clinical trial NCT04755283 (Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation).
Product Specification
Alias:NVS250519, F11, anti-F11
Clonity:Monoclonal
Host:CHO Cells
Species:Human
Target:F11
Isotype:IgG1 Lambda
Size:100ug, 1mg, 5mg
Research Area:Cardiovascular
CAS Number:2098724-83-3
Molecular Weight:147.32KDa
Application:ELISA, FACS, Functional Assay, In Vivo
Alternate Names:2098724-83-3, Abelacimab Biosimilar, f11 antibody, biosimilar monoclonal antibodies, Research Grade Biosimilar, biosimilar antibodies, f11 blocking antibody, f11 blocking antibodies, anti-f11 recombinant antibody, f11 recombinant antibody
Purity:>95% as determined by SDS-PAGE
Concentration:batch dependent
Buffer:Supplied in PBS, PH7.5
Storage:Store at -20 °C for 12 months. Store at -80 °C for long term storage.
Note:This product is for research use only.